PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Sep-2023 Interim results for the six months to 30 June 2023 Poolbeg Pharma plc
13-Sep-2023 Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advance Mainz BioMed N.V.
13-Sep-2023 Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock Businesswire
13-Sep-2023 United States Concierge Medicine Market: Crafting Customized Wellness, Poised to Reach US$ 17.97 Billion by 2033 MARKITWIRED
13-Sep-2023 Lupus Nephritis Treatment Market: Nurturing Lupus Wellness, Attains US$ 5.67 Billion Valuation by 2033 MARKITWIRED
13-Sep-2023 “Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market: Empowering Kidney Resilience, Anticipating US$ 4.89 Billion Valuation by 2033 MARKITWIRED
13-Sep-2023 Developmental and Epileptic Encephalopathies (DEE) Treatment Market: Nurturing Neurodevelopment, Aiming for US$ 11.4 Billion by 2033 MARKITWIRED
13-Sep-2023 Cardiogenic Shock Treatment Market: Healing Strained Hearts, Envisions US$ 1.77 Billion Valuation by 2033 MARKITWIRED
13-Sep-2023 Artificial Intelligence applied to medicine: Strategic investors support IOMED's internationalization IOMED
13-Sep-2023 Evolva and Nice & Green agree on improvements to financing agreement Evolva Holding SA
13-Sep-2023 Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Integra LifeSciences Holdings Corporation Businesswire
13-Sep-2023 Final Deadline Approaching for Bausch Health Companies Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. (BHC) Investors of September 25, 2023 Lead Plaintiff Deadline Businesswire
13-Sep-2023 Life Sciences BC Announces Incoming Board of Directors Businesswire
12-Sep-2023 Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023 Businesswire
12-Sep-2023 Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock Businesswire
12-Sep-2023 Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease Businesswire
12-Sep-2023 Celyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SA Businesswire
12-Sep-2023 Marinus Pharmaceuticals Announces Speakers for Hybrid Investor & Analyst Event on Tuesday, September 19, 2023 Businesswire
12-Sep-2023 New US Prescription Drugs Cost Now More Than $200K on Average Newswire
12-Sep-2023 MorphoSys Receives U.S. FDA Fast Track Designation for Tulmimetostat in Endometrial Cancer MorphoSys AG